These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20017838

  • 1. Bottom-up nanotechnology: the human nephron filter.
    Nissenson AR.
    Semin Dial; 2009; 22(6):661-4. PubMed ID: 20017838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The human nephron filter: toward a continuously functioning, implantable artificial nephron system.
    Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R.
    Blood Purif; 2005; 23(4):269-74. PubMed ID: 15908745
    [Abstract] [Full Text] [Related]

  • 4. The future of renal replacement therapy.
    Rastogi A, Nissenson AR.
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):249-55. PubMed ID: 17603978
    [Abstract] [Full Text] [Related]

  • 5. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C.
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [Abstract] [Full Text] [Related]

  • 6. Development of continuous implantable renal replacement: past and future.
    Fissell WH, Fleischman AJ, Humes HD, Roy S.
    Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
    [Abstract] [Full Text] [Related]

  • 7. Problems and solutions for artificial kidney.
    Vanholder R.
    Technol Health Care; 2000 Dec; 8(6):373-9. PubMed ID: 11258583
    [Abstract] [Full Text] [Related]

  • 8. Challenges and future of renal replacement therapy.
    de Francisco AL, Piñera C.
    Hemodial Int; 2006 Jan; 10 Suppl 1():S19-23. PubMed ID: 16441862
    [Abstract] [Full Text] [Related]

  • 9. The implantable artificial kidney.
    Fissell WH, Roy S.
    Semin Dial; 2009 Jan; 22(6):665-70. PubMed ID: 20017839
    [Abstract] [Full Text] [Related]

  • 10. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R, Polkinghorne KR, Kerr PG.
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [Abstract] [Full Text] [Related]

  • 11. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J, Granolleras C, Deschodt G, Heck M, Baudin G, Branger B, Tournier O, Reinhard B, Eisenbach GM, Smeby LC.
    Nephrol Dial Transplant; 1989 Jul; 4(7):653-7. PubMed ID: 2510064
    [Abstract] [Full Text] [Related]

  • 12. History and development of continuous renal replacement techniques.
    Burchardi H.
    Kidney Int Suppl; 1998 May; 66():S120-4. PubMed ID: 9573587
    [Abstract] [Full Text] [Related]

  • 13. Technological advances in renal replacement therapy: five years and beyond.
    Rastogi A, Nissenson AR.
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S132-6. PubMed ID: 19995997
    [Abstract] [Full Text] [Related]

  • 14. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT, Williams AW, Johnson WJ.
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [Abstract] [Full Text] [Related]

  • 15. Rationale and experience with short daily hemofiltration.
    Jaber BL, Zimmerman DL.
    Semin Dial; 2004 Apr; 17(2):146-50. PubMed ID: 15043618
    [Abstract] [Full Text] [Related]

  • 16. The future of renal support: high-flux dialysis to bioartificial kidneys.
    Tiranathanagul K, Eiam-Ong S, Humes HD.
    Crit Care Clin; 2005 Apr; 21(2):379-94. PubMed ID: 15781170
    [Abstract] [Full Text] [Related]

  • 17. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G, Jaber BL.
    Semin Dial; 2009 Apr; 22(6):610-4. PubMed ID: 20017830
    [Abstract] [Full Text] [Related]

  • 18. Replacement of renal function in uremic animals with a tissue-engineered kidney.
    Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF.
    Nat Biotechnol; 1999 May; 17(5):451-5. PubMed ID: 10331803
    [Abstract] [Full Text] [Related]

  • 19. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C, Gutzwiller JP, Renggli K.
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [Abstract] [Full Text] [Related]

  • 20. Technology insight: Innovative options for end-stage renal disease--from kidney refurbishment to artificial kidney.
    Braam B, Verhaar MC, Blankestijn P, Boer WH, Joles JA.
    Nat Clin Pract Nephrol; 2007 Oct; 3(10):564-72. PubMed ID: 17895933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.